Preview

Rational Pharmacotherapy in Cardiology

Advanced search

FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS

https://doi.org/10.20996/1819-6446-2010-6-5-697-702

Full Text:

Abstract

Peculiarities of the mode of action and clinical use of fixed low-dose combination of lisinopril and hydrochlorothiazide are discussed. Reasonability of ACE inhibitor and thiazide diuretic combination is supported due to more effective blood pressure control, organoprotection improvement and side events risk reduction. Results of the clinical studies on efficacy and safety of this combination in hypertensive patients with different concomitant diseases are presented.

About the Authors

A. O. Shevchenko
N.I. Pirogov Russian State Medical University
Russian Federation
Ostrovityanova ul. 1, Moscow, 117997


O. P. Shevchenko
N.I. Pirogov Russian State Medical University
Russian Federation
Ostrovityanova ul. 1, Moscow, 117997


References

1. Balanova Yu.A., Vilkov V.G., Dotsenko A.N. et al. Results of the second stage of monitoring the epidemiological situation of hypertension in the Russian Federation (2005-2007) within the Federal Target Program “Prevention and treatment of hypertension”. Information and statistical book. M.: GNITs PM; 2008. Russian (Баланова Ю.А., Вилков В.Г., Доценко А.Н. и др. Результаты второго этапа мониторинга эпидемиологической ситуации по артериальной гипертонии в Российской Федерации (2005-2007 гг.) в рамках Федеральной целевой программы “Профилактика и лечение артериальной гипертонии”. Информационно-статистический сборник. М.: ГНИЦ ПМ; 2008).

2. National guidelines for diagnosis and treatment of hypertension. The Experts Committee of RMSAH and RSSC. Kardiovaskulyarnaya terapiya i profilaktika 2008; 7(6) prilozhenie 2:3-32. Russian (Национальные рекомендации по диагностике и лечению артериальной гипертонии. Комитет экспертов РМОАГ и ВНОК. Кардиоваскулярная терапия и профилактика 2008; 7(6) приложение 2:3-32).

3. Ernst M.E., Gordon J.A.Diuretic therapy: key aspects in hypertension and renal disease. J Nephrol 2010; 23(5): 487 - 493

4. Turnbull F., Neal B., Algert C. et al. Effects of different blood pressure lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 2005;165(12):1410–1419

5. Psaty B.M., Lumley T., Furberg C.D. et al.Health outcomes associated with various antihypertensive therapies used as firstline agents: a network meta-analysis. JAMA 2003;289(19):2534-44.

6. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: metaanalysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.

7. Turnbull F; Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pres￾sure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362(9395):1527-1535

8. de Carvalho J.G., Dunn F.G., Lohmoller G., Frohlich E.D. Hemodynamic correlates of prolonged thiazide therapy: comparison of responders and nonresponders. Clin Pharmacol Ther 1977;22(6):875-80

9. Hughes A.D. How do thiazide and thiazide-like diuretics lower blood pressure? J Renin Angiotensin Aldosterone Syst 2004;5(4):155-60

10. Stamler R., StamlerJ., Grimm R. et al. Nutritional therapy for high blood pressure: finalreport of a fouryear randomized controlled trial — the Hypertension Control Program. JAMA 1987;257(11): 1484-91.

11. Uretsky B.F., Shaver J.A., Liang C.S. et al. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin-converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional and biochemicalresponses. Am Heart J 1988;116(2 Pt 1):480–488.

12. Gilbert E.M., et al. Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart. Circulation 1993;88(2);472-480.

13. Boger-Megiddo I., Heckbert S.R., Weiss N.S. et al. Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study. BMJ 2010;340:c103

14. Patel B.V., Remigio-Baker R.A., Thiebaud P. et al. Improved persistence and adherence to diuretic fixeddose combination therapy compared to diuretic monotherapy. BMC Fam Pract 2008; 9:61.

15. MotwaniJ.G. Combining renin-angiotensin-aldosterone system blockade with diuretic therapy fortreatment of hypertension. JRAAS 2002;3(2):72-8.

16. Keinänen-Kiukaanniemi S., Rasmusen M., Pekkarinen T. et al. Effects of lisinopril or lisinopril/hydrochlorothiazide compared with adjusting of previous medication and intensifying non-pharmacological treatment in patients with mild to moderate hypertension. Arzneimittelforschung 1997;47(2):144-50.

17. Epstein M., Bakris G. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. Arch Intern Med 1996;156(17): 1969-1978.

18. Frank J. Managing hypertension using combination therapy. Am Fam Physician 2008;77(9): 1279-1286.

19. Gerc V., Begović B., Vehabović M. et al. Fixed combination lisinopril plus hydro-chlorothiazide in the treatment of essential arterial hypertension: an opened, multi-centre, prospective clinical trial. Bosn J Basic Med Sci 2007;7(4):377-82.

20. Gerc V., Begović B., Vehabović M. et al. Effects of fixed combination of lisinopril plus hydrochlorothiazide on regression of left ventricular hypertrophy in patients with essential hypertension: an opened, multi-centre, prospective clinical trial. Bosn J Basic Med Sci 2008;8(3):214-9.

21. Boydak B., Nalbantgil S., Yilmaz H. et al. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension. Saudi Med J 2004;25(12):1975-8.

22. L'Allier P.L., Ducharme A., Keller P.F. et al. Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. J Am Coll Cardiol 2004; 44(1):159-64.

23. Prisant L. M., Neutel J. M., Ferdinand K. et al. Hall, and M. R. Weir. Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks. J Natl Med Assoc 1999; 91(1): 40–48.

24. Law M.R., Wald N.J., Morris J.K., Jordan R.E. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326(7404):1427

25. Lee A.F., Dick J.B., Bonnar C.E., Struthers A.D. Lisinopril improves arterial function in hyperlipidaemia. Clin Sci 1999;96(5):441-8

26. Greenberg A. Diuretic complications. Am J Med Sci 2000;319(1):10-24.

27. The ALLHAT Collaborative Research Group Major Outcomes in High-Risk Hypertensive Patients Randomized to ACE Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288(23):2981-2997.

28. Whelton P.K., Barzilay J., Cushman W.C. et al. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2005;165(12): 1401-1409

29. Chrysant S.G. Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group. Arch Intern Med 1994;154(7): 737-43.

30. Zillich A.J., Garg J., Basu S. et al. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006;48(2):219-224.

31. Koster J.C., Remedi M.S., Masia R. et al. Expression of ATP-insensitive KATP channels in pancreatic beta-cells underlies a spectrum of diabetic phenotypes. Diabetes 2006;55(11): 2957-2964.

32. Shafi T., Appel L.J., Miller E.R. 3rd et al. Changes in serum potassium mediate thiazide-induced diabetes. Hypertension 2008;52(6):1022-1029.

33. Reisin E., Weir M.R., Falkner B. et al. Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group. Hypertension 1997; 30 (1 Pt 1):140-145.

34. Chaturvedi N., Sjolie A.K., Stephenson J.M. et al. Effects of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 1998; 351(9095): 28-31.

35. Henriksen E.J., Jacob S. Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition. J Cell Physiol 2003;196(1):171-9.

36. Mogensen C.E., Neldam S., Tikkanen I. et al. Randomised controlled trial of dual blockade of reninangiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 2000;321(7274): 1440-4.

37. Bakris G.L., Toto R.D., McCullough P.A. et al. Effects of differentACE inhibitor combinations on albuminuria: results of the GUARD study. Kidney Int 2008;73(11):1303-1309.

38. Rigaud A.S., Forett B. Hypertension in older adults. J Gerontol A Biol Sci Med Sci 2001;56(4): M217-25.

39. Lipsitz L.A., Gagnon M., Vyas M. et al. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension 2005; 45(2): 216-221.


For citation:


Shevchenko A.O., Shevchenko O.P. FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS. Rational Pharmacotherapy in Cardiology. 2010;6(5):697-702. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-5-697-702

Views: 530


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)